The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTrifast Regulatory News (TRI)

Share Price Information for Trifast (TRI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 73.20
Bid: 73.20
Ask: 77.80
Change: 0.00 (0.00%)
Spread: 4.60 (6.284%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 73.20
TRI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

12 Mar 2021 17:48

RNS Number : 1763S
Trifast PLC
12 March 2021
 

 

 

 

12 March 2021

 

Trifast plc

("Trifast" or the "Company")

 

Notification and public disclosure of transactions by Persons Discharging

Managerial Responsibilities and Total Voting Rights

 

Increase in PDMR shareholding

The Company announces that Ms. Clare Foster, Chief Financial Officer of the Company, a Person Discharging Managerial Responsibilities ("PDMR"), was issued and allotted a total of 60,000 ordinary shares of 5 pence each in the Company ("Ordinary Shares") on 9 March 2021 pursuant to the exercise of options under the Company's 2017 Deferred Equity Bonus Share scheme. Immediately following this, Clare completed a sale of 60,000 ordinary shares and repurchase of 14,518 ordinary shares through her ISA.

 

Ms. Foster also transferred 14,518 ordinary shares to her partner's ISA.

 

Details of the transactions are shown in the PDMR notifications below.

 

Following the transactions listed above Ms. Foster and Persons Closely Associated with her remain beneficially interested in 88,886 ordinary shares of the Company.

 

Total Voting Rights (TVR)

Following the issue and allotment of shares, the Company's total issued share capital is 136,023,890 Ordinary Shares with one voting right per share. The Company does not hold any Ordinary Shares in Treasury. Therefore, the total number of voting rights in the Company is 136,023,890. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

 

Trifast plc

Lyndsey Case

Company Secretary

Tel: 44 (0) 1825 769696

www.trifast.com 

 

The notification below is made in accordance with the requirements of the EU Market Abuse Regulation.

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Clare Foster

2.

Reason for the notification

a.

Position/status

Chief Financial Officer

b.

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Trifast plc

b.

LEI

213800WFIVE6RWK3CR22

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the financial instrument, type of instrument Identification code

Ordinary shares of 5 pence each 

GB0008883927

b.

Nature of the transaction

Allotment of shares pursuant to the exercise of options under the Company's 2017 Deferred Equity Bonus Share scheme

c.

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

60,000 

d.

Aggregated information

Aggregated volume

Price

 

60,000

Nil

e.

Date of the transaction

9 March 2021

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

5.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the financial instrument, type of instrument Identification code

Ordinary shares of 5 pence each 

GB0008883927

b.

Nature of the transaction

Sale of 58,316 ordinary shares of 5p each in the Company ("Ordinary Shares")

c.

Price(s) and volume(s)

 

Price(s)

Volume(s)

128.5p

58,316 

d.

Aggregated information

 

 

 

Price(s)

Aggregated Price

Aggregated Volume(s)

128.5p

£74,936.06

58,316 

e.

Date of the transaction

11 March 2021

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

6.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the financial instrument, type of instrument Identification code

Ordinary shares of 5 pence each 

GB0008883927

b.

Nature of the transaction

Sale of 1,684 ordinary shares of 5p each in the Company ("Ordinary Shares") where 14,518 Ordinary Shares were immediately repurchased by Clare Foster through a Bed and ISA arrangement and 14,518 Ordinary Shares were purchased by Clare's partner through a Bed and ISA arrangement.

c.

Price(s) and volume(s)

Transaction 1 (sale)

Transaction 2 (purchase (own ISA))

Transaction 3 (purchase (partner's ISA))

Price(s)

Volume(s)

131.5p

1,684

135.0p

14,518

135.0p

14,518

d.

Aggregated information

 

 

Transaction 1 (sale)

Transaction 2 (purchase (own ISA))

Transaction 3 (purchase (partner's ISA))

 

Price(s)

Aggregated Price

Aggregated Volume(s)

131.5p

£2,214.46

1,684

135.0p

£19,599.30

14,518

135.0p

£19,599.30

14,518

e.

Date of the transaction

12 March 2021

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHDZGMFNZFGMZM
Date   Source Headline
25th Apr 20247:00 amRNSTrading update & Notice of Annual results
15th Apr 20242:11 pmRNSDirector/PDMR Shareholding
15th Apr 20241:07 pmRNSDirector/PDMR Shareholding
4th Apr 202410:40 amRNSBlock listing Interim Review
21st Mar 20247:00 amRNSDirector/PDMR Shareholding - Purchase of shares
13th Mar 20242:30 pmRNSDirector/PDMR Shareholding
11th Mar 20247:00 amRNSAppointment & retirement of non-executive director
22nd Feb 20247:00 amRNSDirectorate Change
9th Feb 20247:00 amRNSHolding(s) in Company
1st Feb 202410:09 amRNSHolding(s) in Company
1st Feb 20247:00 amRNSTotal Voting Rights
31st Jan 20249:33 amRNSHolding(s) in Company
24th Jan 20247:00 amRNSDirector/PDMR Shareholding
23rd Jan 202411:23 amRNSDirector/PDMR Shareholding
22nd Jan 20243:20 pmRNSDirector/PDMR Shareholding
22nd Jan 20247:00 amRNSTrading Update
3rd Jan 20245:50 pmRNSTotal Voting Rights
21st Dec 20234:24 pmRNSHolding(s) in Company
21st Dec 20234:18 pmRNSHolding(s) in Company
15th Dec 20237:00 amRNSNon executive director retirement update
1st Dec 20237:00 amRNSDirector/PDMR Shareholding
30th Nov 20237:00 amRNSPDMR - Performance conditions for LTIP award
24th Nov 20232:34 pmRNSDirector/PDMR shareholding - Purchase of shares
21st Nov 20237:00 amRNSHalf-year Report - six months to 30 September 2023
24th Oct 20237:00 amRNSHalf year trading update and notice of results
19th Oct 20237:00 amRNSNon-executive Director appointment
12th Oct 20237:00 amRNSDirectorate retirement
3rd Oct 20234:16 pmRNSBlock listing Interim Review
25th Sep 20233:49 pmRNSHolding(s) in Company
19th Sep 20234:45 pmRNSPDMR Save As You Earn Plan grant of Option
15th Sep 20233:05 pmRNSResult of AGM
15th Sep 20239:15 amRNSCEO appointment
14th Sep 20234:48 pmRNSDirectorate Change
29th Aug 20237:00 amRNSHolding(s) in Company
10th Aug 20237:00 amRNSBoard Appointment
3rd Aug 202311:36 amRNSDirector/PDMR Shareholding
19th Jul 20232:31 pmRNSHolding(s) in Company
19th Jul 20237:00 amRNSAR posting - AGM - Sustainability report & TVR
17th Jul 20231:25 pmRNSHolding(s) in Company
11th Jul 20237:00 amRNSAnnual results - 31 March 2023 - Annual Report
9th Jun 20237:00 amRNSNotice of Annual Results
10th May 202311:38 amRNSHolding(s) in Company
4th May 20233:50 pmRNSDirector Declaration
26th Apr 20237:00 amRNSTrading update
4th Apr 20234:45 pmRNSTotal Voting Rights
4th Apr 20234:43 pmRNSBlock listing Interim Review
29th Mar 20234:47 pmRNSHolding(s) in Company
28th Feb 20236:16 pmRNSPDMR Shareholding
28th Feb 20231:38 pmRNSDirector/PDMR Shareholdings
27th Feb 20233:14 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.